Valacyclovir Provides Optimum Acyclovir Exposure for Prevention of Cytomegalovirus and Related Outcomes after Organ Transplantation
Open Access
- 15 October 2002
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 186 (s1) , S110-S115
- https://doi.org/10.1086/342965
Abstract
A meta-analysis of 12 randomized trials (1574 patients) examined herpesvirus and related outcomes following organ transplantation over a range of acyKeywords
This publication has 25 references indexed in Scilit:
- Valganciclovir Results in Improved Oral Absorption of Ganciclovir in Liver Transplant RecipientsAntimicrobial Agents and Chemotherapy, 2000
- Acyclovir Is Phosphorylated by the Human Cytomegalovirus UL97 ProteinAntimicrobial Agents and Chemotherapy, 1999
- Valacyclovir for the Prevention of Cytomegalovirus Disease after Renal TransplantationNew England Journal of Medicine, 1999
- Quantity of cytomegalovirus viruria is a major risk factor for cytomegalovirus disease after renal transplantationJournal of Medical Virology, 1997
- A PROSPECTIVE RANDOMIZED STUDY OF ACYCLOVIR VERSUS GANCICLOVIR PLUS HUMAN IMMUNE GLOBULIN PROPHYLAXIS OF CYTOMEGALOVIRUS INFECTION AFTER SOLID ORGAN TRANSPLANTATION1,2Transplantation, 1994
- THE COST IMPACT OF CYTOMEGALOVIRUS DISEASE IN RENAL TRANSPLANT RECIPIENTSTransplantation, 1993
- Impact of Cytomegalovirus Infection on Organ Transplant RecipientsClinical Infectious Diseases, 1990
- A Randomized, Placebo-Controlled Trial of Oral Acyclovir for the Prevention of Cytomegalovirus Disease in Recipients of Renal AllograftsNew England Journal of Medicine, 1989
- THE ADVERSE IMPACT OF CYTOMEGALOVIRUS INFECTION ON CLINICAL OUTCOME IN CYCLOSPORINE-PREDNISONE TREATED RENAL ALLOGRAFT RECIPIENTSTransplantation, 1988
- Primary cytomegalovirus and opportunistic infections. Incidence in renal transplant recipientsJAMA, 1978